Spelling suggestions: "subject:"transforming growth factor beta11"" "subject:"transforming growth factor beta.a1""
11 |
T-Zell Gedächtnis und Zytokinmilieu bei Kopf-Hals-TumorenZiouta, Yvonne. January 2006 (has links)
Heidelberg, Univ., Diss., 2006.
|
12 |
Zeitliche Expressionsprofile der Zytokine-Interleukin-1-beta, Interleukin-6 und transforming growth factor-beta 1 mittels Real-time-Polymerase-Kettenreaktion (rt-PCR) im Myelonkompressionsmodell der RatteRingelstein, Marius January 2007 (has links)
Zugl.: Aachen, Techn. Hochsch., Diss.
|
13 |
Einfluss experimentell modifizierter LTBP-4-Genexpression auf das Expressionsprofil von TGF-[beta]1 [TGF-Beta1], p21 und c-myc in HEK293T ZellenNiggemeyer, Marie Nicola January 1900 (has links)
Zugl.: Berlin, Freie Univ., Diss., 2007
|
14 |
Bone tissue engineering from marrow stromal cells : effects of growth factors and biomaterialsLieb, Esther January 2004 (has links)
Regensburg, Univ., Diss., 2003. / Erscheinungsjahr an der Haupttitelstelle: 2003.
|
15 |
Molekulare Mechanismen der Antiöstrogenwirkung beim MammakarzinomBuck, Miriam. January 2002 (has links)
Stuttgart, Univ., Diss., 2002.
|
16 |
Eventos moleculares associados ao aumento gengival induzido por ciclosporina A são atenuados pela superexpressão de Smad7 / Molecular events associated with cyclosporin A induced gingival overgrowth are attenuated by Smad 7 overexpressionBersaneti, Joseli Assem, 1964- 18 August 2018 (has links)
Orientador: Ricardo Della Coletta / Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Odontologia de Piracicaba / Made available in DSpace on 2018-08-18T17:48:45Z (GMT). No. of bitstreams: 1
Bersaneti_JoseliAssem_D.pdf: 811147 bytes, checksum: f8bb5e097207f57ec74bd4e214234d0b (MD5)
Previous issue date: 2011 / Resumo: O aumento gengival induzido por ciclosporina A (CsA) é causado por um acúmulo excessivo de matriz extracelular, resultado da ação do fator de crescimento transformante-beta 1 (TGF-ß1) sobre a atividade dos fibroblastos gengivais. O presente estudo investigou in vitro os efeitos da superexpressão de Smad7, um inibidor da sinalização de TGF-ß1, nos eventos biológicos associados ao acúmulo de matriz extracelular induzido por CsA. Para verificar os efeitos inibitórios de Smad7, nós superexpressamos Smad7 em fibroblastos de gengiva normal (GN) de uma maneira estável. Células superexpressando Smad7 e células controle foram incubadas com CsA e a síntese de colágeno tipo I, produção e atividade de metaloproteinase de matriz 2 (MMP-2) e proliferação celular foram analisadas por ELISA, zimografia, curva de crescimento, método de incorporação de bromodeoxiuridina (BrdU) e análise do ciclo celular. Os efeitos de CsA na viabilidade celular e apoptose dos fibroblastos de GN também foram avaliados. Análises de western blot e imunofluorescência para fosforo-Smad2 foram realizados para verificar a ativação da cascata de sinalização de TGF-ß1. Apesar do tratamento com CsA estimular a produção de TGF-ß1 tanto nas células controle quanto nos fibroblastos superexpressando Smad7, a via de sinalização de TGF-ß1 foi marcantemente inibida nas células superexpressando Smad7, como revelado pelos níveis reduzidos de fosforilação de Smad2. Nas células superexpressando Smad7, os efeitos de CsA na proliferação, síntese de colageno tipo I e produção e atividade de MMP-2 foram significativamente bloqueados. A superexpressão de Smad7 bloqueou a proliferação dos fibroblastos gengivais induzida por CsA via regulação de p27. CsA e a superexpressão de Smad7 não induziram morte celular. Os resultados deste estudo confirmaram que a expressão de TGF-ß1 é correlacionada com os eventos moleculares associados ao aumento gengival induzido por CsA, e sugerem que a superexpressão de Smad7 é efetiva no bloqueio de tais eventos, incluindo proliferação, síntese de colágeno tipo I e atividade de MMP-2 / Abstract: Cyclosporin A (CsA)-induced gingival overgrowth is attributed to an exaggerated accumulation of extracellular matrix, which is mainly due to an increased expression of transforming growth factor-beta1 (TGF-ß1). Herein the in vitro investigation of effects of overexpression of Smad7, a TGF-ß1 signaling inhibitor, in the events associated with CsA-induced extracellular matrix accumulation was performed. To assess the inhibitory effects of Smad7, we stably overexpressed Smad7 in fibroblasts from normal gingiva (NG). Smad7 overexpressing cells and controls were incubated with CsA and type I collagen synthesis, matrix metalloproteinase 2 (MMP-2) production and activity, and cellular proliferation were evaluated by ELISA, zymography, growth curve, BrdUincorporation assay and cell cycle analysis. CsA effects on cell viability and apoptosis of NG fibroblasts were also evaluated. Western blot and immunofluorescence for phospho-Smad2 were performed to measure the activation of TGF-ß1 signaling. Although the treatment with CsA stimulated TGF-ß1 production in both control and Smad7 overexpressing fibroblasts, its signaling was marked inhibited in Smad7 overexpressing cells as revealed by low levels of Smad2 phosphorylation. In Smad7 overexpressed cells, the effects of CsA on proliferation, synthesis of type I collagen and MMP-2 production and activity were significantly blocked. Smad7 overexpression blocked CsA-induced fibroblast proliferation via p27 regulation. Neither CsA nor Smad7 overexpression induced cell death. The data presented here confirm that TGF-ß1 expression is related to the molecular events associated with CsA-induced gingival overgrowth, and suggest that Smad7 overexpression is effective in the blockage of those events, including proliferation, type I collagen synthesis and MMP-2 activity / Doutorado / Estomatologia / Doutor em Estomatopatologia
|
17 |
Fibrose cardíaca em camundongos mdx idosos = efeito da suramina, um bloqueador do TGF-ß1 / Cardiac fibrosis in older mdx mice : effects of sumarim, a blocker of TGF-ß1Moreira, Drielen de Oliveira, 1985- 20 August 2018 (has links)
Orientador: Maria Julia Marques / Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas / Made available in DSpace on 2018-08-20T07:19:08Z (GMT). No. of bitstreams: 1
Moreira_DrielendeOliveira_M.pdf: 2075338 bytes, checksum: 00bb5917e4f176b73c58453340cb3a5e (MD5)
Previous issue date: 2012 / Resumo: A Distrofia muscular de Duchenne (DMD) é uma doença caracterizada pela fraqueza muscular progressiva que leva à insuficiência respiratória e cardíaca, resultando em morte por volta dos 30 anos de idade. No camundongo mdx, modelo experimental da DMD, os músculos diafragma e cardíaco são severamente afetados apresentando fibrose semelhante à observada na patologia humana. O objetivo deste trabalho foi investigar os efeitos do tratamento a longo prazo com suramina, uma droga anti-fibrótica, nos músculos diafragma e cardíaco de camundongos mdx idosos. Camundongos mdx (n=20; 8 meses de idade) receberam injeções intraperitoneais de suramina (60 mg/kg), durante 3 meses. Controles mdx (n=20; 8 meses) e C57BL/10 (n=18; 8 meses) foram injetados com solução salina. Os camundongos da linhagem C57BL/10 expressam distrofina e são utilizados como controle da linhagem mdx. A suramina diminuiu os níveis de CK e atenuou a perda da força muscular. No músculo diafragma, a suramina reduziu a área de fibrose e a mionecrose. No músculo cardíaco, houve redução da fibrose, da inflamação e melhora significativa de parâmetros funcionais cardíacos (amplitude das ondas P, Q, R e S do eletrocardiograma). Sugere-se que a suramina possa ser potencialmente útil nas distrofinopatias, atenuando a miopatia nos músculos mais afetados, o coração e o diafragma, nos estágios tardios da doença / Abstract: Duchenne muscular dystrophy (DMD) is a disease characterized by progressive muscle weakness leading to respiratory and cardiac failure, resulting in death around 30 years of age. In the mdx mice model of DMD, diaphragm and cardiac muscles are severely affected in the later stages of the disease, showing intense fibrosis similar to that observed in human pathology. The aim of the present study was to investigate the effects of long-term treatment with suramin, an anti-fibrotic agent, in the diaphragm and cardiac muscles of the mdx mice. Mdx mice (n=20; 8 months of age) received intraperitoneal injections of suramin (60 mg/kg) for 3 months. Mdx controls (n=20; 8 months) and C57BL/10 (n=18; 8 months old) were injected with saline. C57BL/10 mice express dystrophin and are the control strain for the mdx mice. Suramin decreased CK levels and reduced the loss of muscle strength. Suramin reduced fibrosis and myonecrosis in diaphragm. In the cardiac muscle, suramin decreased fibrosis, inflammation and improved cardiac functional parameters (P, Q, R and S waves of the electrocardiogram). It is suggested that suramin may be a potential therapy for distrophinopaties, attenuating the dystrophic phenotype of the most affected cardiac and diaphragm muscles of the mdx mice, during later stages of the disease / Mestrado / Anatomia / Mestre em Biologia Celular e Estrutural
|
18 |
Matrix Remodeling and Hyaluronan Production by Myofibroblasts and Cancer-Associated Fibroblasts in 3D Collagen MatricesSapudom, Jiranuwat, Damaris Müller, Claudia, Nguyen, Khiet-Tam, Martin, Steve, Anderegg, Ulf, Pompe, Tilo 13 April 2023 (has links)
The tumor microenvironment is a key modulator in cancer progression and has become a novel target in cancer therapy. An increase in hyaluronan (HA) accumulation and metabolism can be found in advancing tumor progression and are often associated with aggressive malignancy, drug resistance and poor prognosis. Wound-healing related myofibroblasts or activated cancer-associated fibroblasts (CAF) are assumed to be the major sources of HA. Both cell types are capable to synthesize new matrix components as well as reorganize the extracellular matrix. However, to which extent myofibroblasts and CAF perform these actions are still unclear. In this work, we investigated the matrix remodeling and HA production potential in normal human dermal fibroblasts (NHFB) and CAF in the absence and presence of transforming growth factor beta -1 (TGF-β1), with TGF-β1 being a major factor of regulating fibroblast differentiation. Three-dimensional (3D) collagen matrix was utilized to mimic the extracellular matrix of the tumor microenvironment. We found that CAF appeared to response insensitively towards TGF-β1 in terms of cell proliferation and matrix remodeling when compared to NHFB. In regards of HA production, we found that both cell types were capable to produce matrix bound HA, rather than a soluble counterpart, in response to TGF-β1. However, activated CAF demonstrated higher HA production when compared to myofibroblasts. The average molecular weight of produced HA was found in the range of 480 kDa for both cells. By analyzing gene expression of HA metabolizing enzymes, namely hyaluronan synthase (HAS1-3) and hyaluronidase (HYAL1-3) isoforms, we found expression of specific isoforms in dependence of TGF-β1 present in both cells. In addition, HAS2 and HYAL1 are highly expressed in CAF, which might contribute to a higher production and degradation of HA in CAF matrix. Overall, our results suggested a distinct behavior of NHFB and CAF in 3D collagen matrices in the presence of TGF-β1 in terms of matrix remodeling and HA production pointing to a specific impact on tumor modulation.
|
19 |
Dynamic interplay between activators and repressors of smooth muscle alpha-actin gene transcription during myofibroblast differentiationHariharan, Seethalakshmi 19 August 2014 (has links)
No description available.
|
20 |
The function of TGF-beta1 in ICUAW and the characterization of Sfrp2, a TGF-beta1 target, in skeletal muscle atrophyZhu, Xiaoxi 08 January 2015 (has links)
Transforming growth factor beta 1 (TGF-beta1) ist ein multifunktionales Zytokin, welches eine Rolle in der Sepsis und in der Sepsis-induzierten Myopathie spielen könnte. Weiterhin könnten erhöhte TGF-beta1-Level zur Muskelschwäche, die mit der Intensivpflege assoziiert ist (engl. intensiv care unit-acquired weakness, ICUAW), beitragen. Der TGF-beta1- Signalweg wurde in Skelettmuskelbiopsien von ICUAW-Patienten heraufreguliert. Secreted frizzled related protein 2 (SFRP2) wurde in einer Gen-Set-Anreicherungsanalyse als das am höchsten regulierte Gen identifiziert. Im Mausmodell führten Sepsis und Hunger zu einer verringerten Sfrp2-Expression, während dies in der Denervation-induzierten Skelettmuskelatrophie nicht festzustellen war. In differenzierten C2C12-Myotuben führte TGF-beta1 zu einer verringerten Sfrp2-mRNA- und Proteinexpression. Luciferase-Assays deuteten auf eine TGF-beta1-abhängige Herunterregulation von Sfrp2 hin, welche auf Promoterebene durch mögliche negative regulatorische Elemente im Sfrp2-Promoter vermittelt wurde. Weiterhin wurde eine TGF-beta1 induzierte Muskelatrophie durch transkriptionelle Repression der myosin heavy chain Gene beobachtet. Im Gegensatz dazu veränderte TGF-beta1 nicht den proteasomalen Abbau muskulärer Proteine. Die Genexpression von Tripartite motif containing 63 und F-box only protein 32 war hingegen leicht herunterreguliert. TGF-beta1-induzierte Atrophie in differenzierten C2C12-Myotuben wurde teilweise durch rekombinantes Sfrp2 aufgehoben. Weiterhin wurde eine direkte physikalische Interaktion zwischen Sfrp2 und TGF-beta1 gefunden, welche diesen Effekt verursacht haben könnte. Zusammengefasst lässt sich feststellen, dass der TGF-beta1- Signalweg eine wichtige Rolle in der ICUAW durch Inhibition der myosin heavy chain Expression spielt. TGF-beta1-abhängige Herunterregulation von Sfrp2 könnte zu einer Feedback-Antwort, die das Ausmaß der Atrophie durch TGF-beta1 verstärkt, führen. / Transforming growth factor beta 1 (TGF-beta1) is a multifunctional cytokine that may play a role in sepsis and in sepsis-induced myopathy. Our group speculated that increased TGF-beta1 could contribute to intensive care (ICU)-acquired weakness (ICUAW), a catastrophic muscle disease in critically ill patients. We found that TGF-beta1 signaling in skeletal muscle biopsies of ICUAW patients was upregulated. Secreted frizzled related protein 2 (SFRP2) was the most regulated gene identified by gene set enrichment analysis (GSEA). I then studied the regulation and function of SFRP2 in different skeletal muscle atrophy models. In three mouse models, downregulated Sfrp2 expression was observed in sepsis and starvation, but not in denervation-induced skeletal muscle atrophy. In differentiated C2C12 myotubes, TGF-beta1 downregulated Sfrp2 expression on both mRNA and protein levels. Luciferase assays suggested that TGF-beta1-dependent downregulation of Sfrp2 was mediated at the promoter level through possible negative regulatory elements in the Sfrp2 promoter. I also observed that TGF-beta1-induced muscle atrophy was accompanied by transcriptional repression of myosin heavy chain genes. In contrast, TGF-beta1 did not increase proteasomal degradation of muscular proteins since gene expression of Tripartite motif containing 63 (Trim63) and F-box only protein (Fbxo32) was not upregulated; instead, they were slightly downregulated. TGF- beta1-induced differentiated C2C12 myotube atrophy was partially reversed by recombinant Sfrp2. This inhibitory effect could have resulted from direct interaction between Sfrp2 and TGF-beta1, since I found a physical interaction between these two proteins. Taken together, TGF-beta1 signaling pathway could play an important role in ICUAW via inhibition of myosin heavy chain expression. TGF-beta1-dependent downregulation of Sfrp2 may establish a feedback loop augmenting the atrophic effect of TGF-beta1.
|
Page generated in 0.0722 seconds